Open access · CC-BY
via OpenAlex
Use of Nicotinamide Mononucleotide as Non-Natural Cofactor
Catalysts · 2025 · ▲ 9 citations
Abstract
Nicotinamide mononucleotide (NMN) has emerged as a promising non-natural cofactor with significant potential to transform biocatalysis, synthetic biology, and therapeutic applications. By modulating NAD⁺ metabolism, NMN offers unique advantages in enzymatic reactions, metabolic engineering, and regenerative medicine. This review provides a comprehensive analysis of NMN’s biochemical properties, mechanisms of action, and diverse applications. Emphasis is placed on its role in addressing challenges in multi-enzyme cascades, biofuel production, and the synthesis of high-value chemicals. The paper also highlights critical research gaps, including the need for scalable NMN synthesis methods, improved integration into enzymatic systems, and comprehensive toxicity studies for therapeutic use. Emerging technologies such as AI-driven enzyme design and CRISPR-based genome engineering are discussed as transformative tools for optimizing NMN-dependent pathways. Furthermore, the synergistic potential of NMN with synthetic biology innovations, such as cell-free systems and dynamic regulatory networks, is explored, paving the way for precise and modular biotechnological solutions. Looking forward, NMN’s versatility as a cofactor positions it as a pivotal tool in advancing sustainable bioprocessing and precision medicine. Addressing current limitations through interdisciplinary approaches will enable NMN to redefine the boundaries of metabolic engineering and therapeutic innovation. This review serves as a roadmap for leveraging NMN’s potential across diverse scientific and industrial domains.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/catal15010037
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Naaz, T., & Kim, B.S. (2025). Use of Nicotinamide Mononucleotide as Non-Natural Cofactor. <em>Catalysts</em>. https://doi.org/10.3390/catal15010037
Vancouver
Naaz T, Kim BS. Use of Nicotinamide Mononucleotide as Non-Natural Cofactor. Catalysts. 2025. doi:10.3390/catal15010037.
BibTeX
@article{tahseena2025UseofN,
title = {Use of Nicotinamide Mononucleotide as Non-Natural Cofactor},
author = {Tahseena Naaz and Beom Soo Kim},
journal = {Catalysts},
year = {2025},
doi = {10.3390/catal15010037},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cell Research & Therapy 2019
Open access · CC-BY
Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
Antioxidants 2021
Open access · CC-BY
Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation
Current aging science 2026
Citation only
Molecular Regulation of Bone Remodeling in Osteoporosis and Current Therapeutic Approaches.
World Journal of Gastroenterology 2024
Open access · CC-BY
Recent advances in age-related metabolic dysfunction-associated steatotic liver disease
International Journal of Biomedical Science 2022
Citation only
Therapeutic Potential of NAD+ Precursors and Aging-related Diseases
2025
Open access · CC-BY